TP-6076 Single Dose Pharmacokinetic Study in Mice for Ex Vivo Plasma Protein Binding

StatusActive
Effective start/end date1/10/1830/09/19

Funding

  • Tetraphase Pharmaceuticals Inc.: $28,619.40

Keywords

  • Infectious Diseases